Cargando…

PM395. The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder

Detalles Bibliográficos
Autores principales:	Na, Kyoungsae, Jung, Han-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616331/ http://dx.doi.org/10.1093/ijnp/pyw041.395

Ejemplares similares

The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder
por: Ko, Young-Hoon, et al.
Publicado: (2014)

Religious Coping Strategies for Religious Patients with Schizophrenia and Schizoaffective Disorder
por: Gedevani, E., et al.
Publicado: (2022)

The use of technologies and social media in patients with schizophrenia and schizoaffective disorder
por: Elleuch, O., et al.
Publicado: (2022)

Clinical factors affecting functioning in patients with schizophrenia or schizoaffective disorder
por: Neily, C., et al.
Publicado: (2022)

Risk assessment of agressive behavior in schizophrenia and schizoaffective disorder : a cross-sectional study
por: Mellouli, A., et al.
Publicado: (2023)

PM359. A prospective cohort study for metabolic measures during antipsychotic treatments in patients with schizophrenia and schizoaffective disorder: A cross-sectional analysis of baseline data
por: Kusumi, Ichiro, et al.
Publicado: (2016)

Alcohol Use Disorder and Schizophrenia or Schizoaffective Disorder
por: Archibald, Luke, et al.
Publicado: (2019)

Schizoaffective disorder about 57 cases
por: Kammoun, I.
Publicado: (2021)

Valproate-induced hypothyroidism in schizoaffective disorder
por: Facucho-Oliveira, J., et al.
Publicado: (2022)

Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder
por: Mathalon, Daniel H., et al.
Publicado: (2010)

CT abnormalities in late-onset schizophrenia and schizoaffective disorder correlate with number of psychotic episodes and cognitive dysfunction
por: Savina, M., et al.
Publicado: (2021)

Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?
por: Mattei, Chiara, et al.
Publicado: (2011)

PS282. Prevalence of mental disorders in suicide
por: Kyoungsae, Na, et al.
Publicado: (2016)

Efficacy and tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders
por: Andrade, Chittaranjan
Publicado: (2004)

Efficacy and Tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders
por: Chavda, R.K., et al.
Publicado: (2004)

Measuring Emotional Awareness in Patients With Schizophrenia and Schizoaffective Disorders
por: Maaßen, Eva, et al.
Publicado: (2021)

Clinical Practice Associated with a Switch from and to Ziprasidone during Routine Inpatient Treatment of Patients with Schizophrenia
por: Müller, Matthias J.
Publicado: (2011)

F53. DOSE REDUCTION OF HIGH-DOSE FIRST-GENERATION ANTIPSYCHOTICS OR SWITCH TO ZIPRASIDONE IN LONG-STAY PATIENTS WITH SCHIZOPHRENIA: A 1-YEAR DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL
por: Bogers, Jan, et al.
Publicado: (2018)

5.3 EVIDENCE ON A TRANSDIAGNOSTIC PSYCHOSIS SPECTRUM OF SCHIZOPHRENIA, SCHIZOAFFECTIVE AND PSYCHOTIC BIPOLAR DISORDER IN THE BIPOLAR-SCHIZOPHRENIA NETWORK ON INTERMEDIATE PHENOTYPES (B-SNIP)
por: Reininghaus, Ulrich, et al.
Publicado: (2018)

Schizoaffective disorder: Nosological controversies and absence of specific treatment guidelines
por: García, M. Valtueña, et al.
Publicado: (2021)

Schizoaffective disorder induced by substance abuse: a case report
por: García Carpintero, A., et al.
Publicado: (2022)

Ziprasidone in the treatment of mania in bipolar disorder
por: Nicolson, Stephen E, et al.
Publicado: (2007)

Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil
por: Fulone, Izabela, et al.
Publicado: (2021)

Trauma and Posttraumatic Stress Disorder (PTSD) in Patients with Schizophrenia or Schizoaffective Disorder
por: Lommen, Miriam J. J., et al.
Publicado: (2009)

Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder
por: Amann, B. L., et al.
Publicado: (2015)

Impairment in delay discounting in schizophrenia and schizoaffective disorder but not primary mood disorders
por: Brown, Hannah E., et al.
Publicado: (2018)

Cardiovascular Risk for Patients With and Without Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder
por: Rossom, Rebecca C., et al.
Publicado: (2022)

The continuing story of schizophrenia and schizoaffective disorder: One condition or two?
por: Hartman, Leah I., et al.
Publicado: (2019)

Should schizoaffective disorder be diagnosed cross-sectionally (ICD-11) instead of longitudinally (DSM-5)?: PRO
por: Falkai, P.
Publicado: (2021)

Should schizoaffective disorder be diagnosed cross-sectionally (ICD-11) instead of longitudinally (DSM-5)?: CON
por: Melle, I.
Publicado: (2021)

Impact of Somatic and Addictive Comorbidities on the Quality of Life of Patients With Schizoaffective Disorder: A cross-sectional study
por: Asgharzadeh, M., et al.
Publicado: (2023)

Clinical case of religious delusion in a combination of schizoaffective disorder and epilepsy
por: Gedevani, E., et al.
Publicado: (2022)

Impact of somatic and addictive comorbidities on the quality of life of patients with schizoaffective disorder
por: Bouali, W., et al.
Publicado: (2023)

S189. CARVING A MORE SPECIFIC SUBTYPE OF SCHIZOPHRENIA FOR GENETIC STUDIES: SPORADIC SCHIZOAFFECTIVE BIPOLAR TYPE
por: van der Merwe, Nicolaas, et al.
Publicado: (2018)

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder
por: Ichinose, Mizue, et al.
Publicado: (2021)

395. Safety and Tolerability of Rifampin in Staphylococcal Orthopedic Infections
por: Miller, Andy O, et al.
Publicado: (2019)

Evidence for Distinguishable Treatment Costs among Paranoid Schizophrenia and Schizoaffective Disorder
por: Hirjak, Dusan, et al.
Publicado: (2016)

microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder
por: Perkins, Diana O, et al.
Publicado: (2007)

Social function in schizophrenia and schizoaffective disorder: Associations with personality, symptoms and neurocognition
por: Lysaker, Paul H, et al.
Publicado: (2004)

Blonanserin-induced Mood Alteration in Schizophrenia and Schizoaffective Disorder: Two Cases
por: Min, Aran, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uopac8h0k9hlvq0rmbtshmjk1s